{"entity":{"type":"insider","cik":"0001616200","url":"/insider/0001616200","json_url":"/insider/0001616200.json","name":"Patni Rajiv","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2015-05-07","last":"2019-03-21","span_basis":"filed_date"},"name_variants":[{"name":"Patni Rajiv","source":"filing","n_filings":4,"first_seen":"2015-05-07","last_seen":"2019-03-21"}],"transactions":[{"id":8099170,"accession":"0001209191-19-020785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-020785","line_url":"/filing/0001209191-19-020785#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001616200","owner_name":"Patni Rajiv","owner_display_name":"Patni Rajiv","owner_url":"/insider/0001616200","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2374.0,"shares_display":"2,374","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":18992.0,"total_display":"18,992.00","total_whole":"18,992","shares_owned_after":19141.0,"shares_owned_after_display":"19,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-20","filed_date":"2019-03-21","scope":"insider"},{"id":6822957,"accession":"0001209191-18-021307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-021307","line_url":"/filing/0001209191-18-021307#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001616200","owner_name":"Patni Rajiv","owner_display_name":"Patni Rajiv","owner_url":"/insider/0001616200","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1252.0,"shares_display":"1,252","price_per_share":25.94,"price_display":"25.94","price_state":"stated","total_value":32476.88,"total_display":"32,476.88","total_whole":"32,477","shares_owned_after":21515.0,"shares_owned_after_display":"21,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-22","scope":"insider"},{"id":4903777,"accession":"0001209191-17-022340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-022340","line_url":"/filing/0001209191-17-022340#line-1","is_derivative":false,"issuer_cik":"0001328143","issuer_name":"Adamas Pharmaceuticals Inc","issuer_ticker":"ADMS","issuer_name_source":null,"issuer_url":"/issuer/0001328143","owner_cik":"0001616200","owner_name":"Patni Rajiv","owner_display_name":"Patni Rajiv","owner_url":"/insider/0001616200","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":733.0,"shares_display":"733","price_per_share":17.04,"price_display":"17.04","price_state":"stated","total_value":12490.32,"total_display":"12,490.32","total_whole":"12,490","shares_owned_after":13642.0,"shares_owned_after_display":"13,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-22","scope":"insider"},{"id":8814247,"accession":"0001274644-15-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-15-000037","line_url":"/filing/0001274644-15-000037#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001616200","owner_name":"Patni Rajiv","owner_display_name":"Patni Rajiv","owner_url":"/insider/0001616200","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5050.0,"shares_display":"5,050","price_per_share":3.97,"price_display":"3.97","price_state":"stated","total_value":20048.5,"total_display":"20,048.50","total_whole":"20,049","shares_owned_after":5050.0,"shares_owned_after_display":"5,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-07","filed_date":"2015-05-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001328143","name":"Adamas Pharmaceuticals Inc","url":"/issuer/0001328143","role":"Officer (Chief Medical Officer)","n_filings":3,"first_seen":"2017-03-22","last_seen":"2019-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Officer (Chief Development Officer)","n_filings":1,"first_seen":"2015-05-07","last_seen":"2015-05-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001616200","retrieved_at":"2026-08-22T05:51:25+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}